Exercise Versus Corticosteroid Randomized Clinical Trial for Plantar Fasciitis
A Clinical Trial of a Multi-Element Exercise Program for Plantar Fasciopathy in Workers Required to Stand for Prolonged Periods of Time
2 other identifiers
interventional
56
1 country
1
Brief Summary
Chronic plantar fasciopathy is a painful condition common in the workplace, particularly for those workers required to stand for long periods of time, and is typically associated with point tenderness at heel and arch of the foot. This clinical trial will investigate the effectiveness of an innovative multi-element exercise program versus the standard of care for plantar fasciopathy. The observation period will be 12-weeks. Outcomes are determined through questionnaire and ultrasound imaging. Workers with long-standing plantar fasciopathy who must stand for prolonged periods of time (i.e. \> 6 hours) during their workday will be invited to participate in this study. After ensuring eligibility, each subject will be randomly assigned to either the intervention group who will receive a multi-element exercise program, or the control group who will receive a cortisone injection followed by a stretching program for their calf-muscles (standard of care). The treatment length for both groups will be 12-weeks.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_2
Started May 2011
Shorter than P25 for phase_2
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 14, 2011
CompletedFirst Posted
Study publicly available on registry
February 17, 2011
CompletedStudy Start
First participant enrolled
May 1, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2012
CompletedMarch 22, 2013
March 1, 2013
9 months
February 14, 2011
March 20, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Change from Baseline in Foot and Ankle Disability Index (FADI) at 6 weeks
Patient-centered health-realted quality of life indicator measuriing disability at the foot and ankle.
6 weeks
Change from Baseline in Foot and Ankle Disability Index (FADI) at 12 weeks
Patient-centered health-realted quality of life indicator measuriing disability at the foot and ankle.
12 weeks
Secondary Outcomes (3)
Change in Ultrasound-Based Grading of Pathology at 12 weeks
12 weeks
Change in Acoustoelastographic Analysis of Plantar Fascia Elasticity at 12 Weeks
12 weeks
Change in Visual Analog Scale for Pain at 12 weeks
12 weeks
Study Arms (2)
Exercise
EXPERIMENTALMulti-element exercise protocol involving static and dynamic stretches, deep massage, and balance training.
Standard of Care
ACTIVE COMPARATORThis arm will consist of a single injection of a corticosteroid, followed by stretching exercises for the calf.
Interventions
lateral side step movement involving crossing one foot over the next for 5 sets of 15 cross-overs in each direction
Walking along a straight line on the ground, for 5 sets of 30 strides
The subject stands feet shoulder width apart with one foot ahead of the other and then contracting only calf muscles of the back leg, lifts the heel of the back leg until the metatarsophalangeal joint of that foot is maximally extended. The subject is instructed to concentrate on maintaining balance on the back leg over the first and second metatarsophalangeal joints throughout movement for 5 sets of 15 repetitions.
This exercise is performed initially with eyes open, then with mastery exhibited by being able to hold balance and not touch the ground with contralateral leg performed with eyes closed, then on an unstable surface with and without eyes open for 1 minute.
The foot is placed sideways at the edge of a step. After stabilizing the remainder of the foot and leg, the ankle is inverted and everted to the limits of the range for 3 sets of 15 repetitions.
This stretch is performed while standing in a neutral position and the knee extended the foot is placed on top of a ramp or phone-book elevating the forefoot on the rearfoot (talocrural dorsiflexion) and held for 3 sets of 30 seconds each. Next the foot is again placed on top of a phone-book with the knee flexed approximately 15-20 degrees and held for 3 sets of 30 seconds each.
This deep massage is performed in a sitting position the right foot is crossed over the left while one hand passively extends the right forefoot. The left hand then applies light to moderate pressure in 3-5 second intervals along the length of the medial longitudinal arch. Same procedure is then repeated for the left foot.
A 22-gauge, 1.5" needle and 3 cm syringe filled with 1ml of dexamethasone mixed with 0.5ml of 1% lidocaine. Prior to injection, the skin will be sterilized with povidone-iodine. The needle is inserted 2-3 cm anteromedial to the focal point of pain in the inferior heel near the calcaneal tuberosity and moved toward the tenderest area.
Eligibility Criteria
You may qualify if:
- Adult workers (men and women) between the ages of 19 and 60
- Workers required to stand for 6 hours or more in their respective workplaces
- Diagnosed with plantar fasciopathy (plantar fasciitis). All diagnoses will be made by a physiotherapist based on the presentation of palpable pain at or around the plantar medial heel, in addition to pain during weight-bearing activities and the presence of morning pain.
- Only individuals with pain for longer than 12 months will be included.
You may not qualify if:
- A history of surgery to their plantar fascia
- Osteoarthritis or other degenerative musculoskeletal disorders affecting the lower extremity
- Individuals who have received corticosteroid injections into their affected plantar fascia at any time in the past will be excluded.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of British Columbia
Vancouver, British Columbia, V6Z 1T3, Canada
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jack Taunton, Dr.
University of British Columbia
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 14, 2011
First Posted
February 17, 2011
Study Start
May 1, 2011
Primary Completion
February 1, 2012
Study Completion
April 1, 2012
Last Updated
March 22, 2013
Record last verified: 2013-03